文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

既往射血分数降低的心力衰竭与脓毒症患者液体输注的关联

Association Between Preexisting Heart Failure With Reduced Ejection Fraction and Fluid Administration Among Patients With Sepsis.
PubMed 文献 · JAMA Netw Open · 2022-10-03
一句话结论社区获得性脓毒性休克中,既往HFrEF患者接受指南推荐30 mL/kg静脉液体的几率更低(aOR 0.63),但院内死亡率无显著差异。

该队列研究纳入2013年1月1日至2015年12月31日住院的5278例社区获得性脓毒症成人患者,评估既往射血分数降低的心力衰竭(HFrEF,射血分数≤40%)与指南推荐静脉液体复苏及死亡率的关系。884例(17%)有既往HFrEF,2291例(43%)符合脓毒性休克标准。脓毒性休克合并HFrEF者接受指南推荐静脉液体的比例低于无HFrEF者(96/380 [25%] vs 699/1911 [37%];P < .001),但院内死亡率相似(47/380 [12%] vs 244/1911 [13%];P = .83)。多因素模型中,HFrEF与脓毒症发作后6小时内接受30 mL/kg静脉液体的风险校正几率降低相关(aOR 0.63;95% CI 0.47-0.85;P = .002),风险校正死亡率无显著差异(aOR 0.92;95% CI 0.69-1.24;P = .59),且与静脉液体量无交互作用(aOR 1.00;95% CI 0.98-1.03;P = .72)。

要点

  • 在社区获得性脓毒性休克患者中,合并既往HFrEF者接受指南推荐30 mL/kg静脉液体的比例更低:96/380(25%)vs 699/1911(37%);P < .001。
  • 多因素模型显示,既往HFrEF与6小时内接受30 mL/kg静脉液体的风险校正几率降低独立相关(aOR 0.63;95% CI 0.47-0.85;P = .002)。
  • 脓毒性休克合并与不合并HFrEF者的院内死亡率相似:47/380(12%)vs 244/1911(13%);P = .83。
  • 风险校正后,HFrEF与院内死亡率无显著差异(aOR 0.92;95% CI 0.69-1.24;P = .59),且与静脉液体量无交互作用(aOR 1.00;95% CI 0.98-1.03;P = .72)。
  • 该队列中既往HFrEF常见(884/5278,17%),脓毒性休克占43%(2291/5278)。

适用人群与场景

  • 2013年1月1日至2015年12月31日期间在整合医疗系统内住院的成人患者,具有社区获得性脓毒症且在脓毒症住院前1年内经胸超声心动图评估过心脏功能。
  • 随访至2016年7月1日。
  • 脓毒性休克定义为符合休克标准者,共2291/5278例(43%)。

诊断标准与关键阈值

  • 既往HFrEF定义为脓毒症住院前1年内经胸超声心动图测得射血分数≤40%。
  • 主要结局为脓毒症发作后6小时内给予30 mL/kg静脉液体。

研究设计与关键结果

  • 研究类型:队列研究,纳入5278例社区获得性脓毒症成人患者(2673例男性[51%];中位年龄70岁[IQR 60-81岁];4349例白人[82%];中位SOFA评分4[IQR 3-5]),其中884例(17%)有既往HFrEF。
  • 主要结局:脓毒性休克合并HFrEF者接受指南推荐静脉液体的比例低于无HFrEF者(96/380 [25%] vs 699/1911 [37%];P < .001);多因素模型中HFrEF与6小时内接受30 mL/kg静脉液体的风险校正几率降低相关(aOR 0.63;95% CI 0.47-0.85;P = .002)。
  • 次要结局:脓毒性休克合并与不合并HFrEF者的院内死亡率相似(47/380 [12%] vs 244/1911 [13%];P = .83);风险校正死亡率无显著差异(aOR 0.92;95% CI 0.69-1.24;P = .59);HFrEF与静脉液体量无交互作用(aOR 1.00;95% CI 0.98-1.03;P = .72)。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该队列研究结果提示既往HFrEF在社区获得性脓毒性休克患者中常见,且与接受指南推荐静脉液体的几率降低相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Intravenous fluid administration is recommended to improve outcomes for patients with septic shock. However, there are few data on fluid administration for patients with preexisting heart failure with reduced ejection fraction (HFrEF).

OBJECTIVE: To evaluate the association between preexisting HFrEF, guideline-recommended intravenous fluid resuscitation, and mortality among patients with community-acquired sepsis and septic shock.

DESIGN, SETTING, AND PARTICIPANTS: A cohort study was conducted of adult patients hospitalized in an integrated health care system from January 1, 2013, to December 31, 2015, with community-acquired sepsis and preexisting assessment of cardiac function. Follow-up occurred through July 1, 2016. Data analyses were performed from November 1, 2020, to August 8, 2022.

EXPOSURES: Preexisting heart failure with reduced ejection fraction (≤40%) measured by transthoracic echocardiogram within 1 year prior to hospitalization for sepsis.

MAIN OUTCOMES AND MEASURES: Multivariable models were adjusted for patient factors and sepsis severity and clustered at the hospital level to generate adjusted odds ratios (aORs) and 95% CIs. The primary outcome was the administration of 30 mL/kg of intravenous fluid within 6 hours of sepsis onset. Secondary outcomes included in-hospital mortality, intensive care unit admission, rate of invasive mechanical ventilation, and administration of vasoactive medications.

RESULTS: Of 5278 patients with sepsis (2673 men [51%]; median age, 70 years [IQR, 60-81 years]; 4349 White patients [82%]; median Sequential Organ Failure Assessment score, 4 [IQR, 3-5]), 884 (17%) had preexisting HFrEF, and 2291 (43%) met criteria for septic shock. Patients with septic shock and HFrEF were less likely to receive guideline-recommended intravenous fluid than those with septic shock without HFrEF (96 of 380 [25%] vs 699 of 1911 [37%]; P < .001), but in-hospital mortality was similar (47 of 380 [12%] vs 244 of 1911 [13%]; P = .83). In multivariable models, HFrEF was associated with a decreased risk-adjusted odds of receiving 30 mL/kg of intravenous fluid within the first 6 hours of sepsis onset (aOR, 0.63; 95% CI, 0.47-0.85; P = .002). The risk-adjusted mortality was not significantly different among patients with HFrEF (aOR, 0.92; 95% CI, 0.69-1.24; P = .59) compared with those without, and there was no interaction with intravenous fluid volume (aOR, 1.00; 95% CI, 0.98-1.03; P = .72).

CONCLUSIONS AND RELEVANCE: The results of this cohort study of patients with community-acquired septic shock suggest that preexisting HFrEF was common and was associated with reduced odds of receiving guideline-recommended intravenous fluids.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Powell RE, Kennedy JN, Senussi MH, et al. Association Between Preexisting Heart Failure With Reduced Ejection Fraction and Fluid Administration Among Patients With Sepsis. JAMA Netw Open. 2022. PMID: 36205995. doi:10.1001/jamanetworkopen.2022.35331

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。